Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
A

ADRX

Nasdaq

ADARx Pharmaceuticals, Inc.

Latest disclosureSeptember 30, 2026
Insider score Why 70?
70/ 100
Qualifying buys · 30d
$87.75M

13 purchases · 0 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 94

Limited filing history
All94Buying13Selling0Other81
Filters

Last 30 daysInsiders bought $87.75M · 5 buyers, led by Sr One Capital Management (10% owner) with $27.2M. No qualifying insider sales.

94 trades · September 24, 2026 – September 28, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 94 trades on this page.

Conversion disclosed

Erez Chimovits

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Erez Chimovits

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Erez Chimovits

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Erez Chimovits

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 30, 2026SEC filing
Purchase disclosed

Erez Chimovits

Director

Common Stock

Reported value
$1.05M
Reported price
$17.00 / share
Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Erez Chimovits

Director

Series A Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Erez Chimovits

Director

Series B Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Erez Chimovits

Director

Series B-1 Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Erez Chimovits

Director

Series C Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Carl L. Gordon

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Carl L. Gordon

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Carl L. Gordon

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Carl L. Gordon

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 30, 2026SEC filing
Purchase disclosed

Carl L. Gordon

Director

Common Stock

Reported value
$5.1M
Reported price
$17.00 / share
Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Carl L. Gordon

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Carl L. Gordon

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Carl L. Gordon

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Carl L. Gordon

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 30, 2026SEC filing
Purchase disclosed

Carl L. Gordon

Director

Common Stock

Reported value
$1.05M
Reported price
$17.00 / share
Traded September 28, 2026Filed September 30, 2026SEC filing
Purchase disclosed

Carl L. Gordon

Director

Common Stock

Reported value
$10M
Reported price
$17.00 / share
Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Carl L. Gordon

Director

Series A Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Carl L. Gordon

Director

Series B Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Carl L. Gordon

Director

Series B-1 Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Carl L. Gordon

Director

Series C Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Carl L. Gordon

Director

Series A Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Carl L. Gordon

Director

Series B Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Carl L. Gordon

Director

Series B-1 Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Carl L. Gordon

Director

Series C Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Orbimed Advisors +4 more

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Orbimed Advisors +4 more

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Orbimed Advisors +4 more

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Orbimed Advisors +4 more

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 30, 2026SEC filing
Purchase disclosed

Orbimed Advisors +4 more

Director

Common Stock

Reported value
$5.1M
Reported price
$17.00 / share
Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Orbimed Advisors +4 more

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Orbimed Advisors +4 more

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Orbimed Advisors +4 more

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Orbimed Advisors +4 more

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 30, 2026SEC filing
Purchase disclosed

Orbimed Advisors +4 more

Director

Common Stock

Reported value
$1.05M
Reported price
$17.00 / share
Traded September 28, 2026Filed September 30, 2026SEC filing
Purchase disclosed

Orbimed Advisors +4 more

Director

Common Stock

Reported value
$10M
Reported price
$17.00 / share
Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Orbimed Advisors +4 more

Director

Series A Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Orbimed Advisors +4 more

Director

Series B Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Orbimed Advisors +4 more

Director

Series B-1 Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Orbimed Advisors +4 more

Director

Series C Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Orbimed Advisors +4 more

Director

Series A Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Orbimed Advisors +4 more

Director

Series B Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Orbimed Advisors +4 more

Director

Series B-1 Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Orbimed Advisors +4 more

Director

Series C Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 30, 2026SEC filing
Conversion disclosed

Sr One Capital Management

10% owner

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

Sr One Capital Management

10% owner

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

Sr One Capital Management

10% owner

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 29, 2026SEC filing
Purchase disclosed

Sr One Capital Management

10% owner

Common Stock

Reported value
$10.07M
Reported price
$17.00 / share
Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

Sr One Capital Management

10% owner

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 29, 2026SEC filing
Purchase disclosed

Sr One Capital Management

10% owner

Common Stock

Reported value
$7.05M
Reported price
$17.00 / share
Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

Sr One Capital Management

10% owner

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

Sr One Capital Management

10% owner

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 29, 2026SEC filing
Purchase disclosed

Sr One Capital Management

10% owner

Common Stock

Reported value
$10.07M
Reported price
$17.00 / share
Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

Sr One Capital Management

10% owner

Series B Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

Sr One Capital Management

10% owner

Series B-1 Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

Sr One Capital Management

10% owner

Series C Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

Sr One Capital Management

10% owner

Series C Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

Sr One Capital Management

10% owner

Series B Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

Sr One Capital Management

10% owner

Series B-1 Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

Simeon George

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

Simeon George

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

Simeon George

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 29, 2026SEC filing
Purchase disclosed

Simeon George

Director

Common Stock

Reported value
$10.07M
Reported price
$17.00 / share
Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

Simeon George

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 29, 2026SEC filing
Purchase disclosed

Simeon George

Director

Common Stock

Reported value
$7.05M
Reported price
$17.00 / share
Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

Simeon George

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

Simeon George

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 29, 2026SEC filing
Purchase disclosed

Simeon George

Director

Common Stock

Reported value
$10.07M
Reported price
$17.00 / share
Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

Simeon George

Director

Series B Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

Simeon George

Director

Series B-1 Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

Simeon George

Director

Series C Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

Simeon George

Director

Series C Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

Simeon George

Director

Series B Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

Simeon George

Director

Series B-1 Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

LAV Biosciences Fund V +2 more

10% owner

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

LAV Biosciences Fund V +2 more

10% owner

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

LAV Biosciences Fund V +2 more

10% owner

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

LAV Biosciences Fund V +2 more

10% owner

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

LAV Biosciences Fund V +2 more

10% owner

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

LAV Biosciences Fund V +2 more

10% owner

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

LAV Biosciences Fund V +2 more

10% owner

Series A Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

LAV Biosciences Fund V +2 more

10% owner

Series B Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

LAV Biosciences Fund V +2 more

10% owner

Series B-1 Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

LAV Biosciences Fund V +2 more

10% owner

Series C Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

LAV Biosciences Fund V +2 more

10% owner

Series C Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 29, 2026SEC filing
Conversion disclosed

LAV Biosciences Fund V +2 more

10% owner

Series C Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 28, 2026Filed September 29, 2026SEC filing
Award disclosed

Rui (NMN) Zhu

Chief Technology Officer

Employee Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 24, 2026Filed September 28, 2026SEC filing
Award disclosed

Alan Robert MacLeod

Chief Scientific Officer

Employee Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 24, 2026Filed September 28, 2026SEC filing
Award disclosed

Ryan Fisk

CFO and CBO

Employee Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 24, 2026Filed September 28, 2026SEC filing
Award disclosed

Zhen Li

President and CEO

Employee Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 24, 2026Filed September 28, 2026SEC filing
Award disclosed

Robert William Ackles

Chief People Officer

Employee Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded September 24, 2026Filed September 28, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
DirectorCommon StockConversion7,127,019Price not reportedUnavailableSep 28Filed Sep 30 · 2d laterSEC filing
DirectorCommon StockConversion1,333,975Price not reportedUnavailableSep 28Filed Sep 30 · 2d laterSEC filing
DirectorCommon StockConversion513,067Price not reportedUnavailableSep 28Filed Sep 30 · 2d laterSEC filing
DirectorCommon StockConversion256,448Price not reportedUnavailableSep 28Filed Sep 30 · 2d laterSEC filing
DirectorCommon StockPurchase61,516$17.00 / share$1.05MSep 28Filed Sep 30 · 2d laterSEC filing
DirectorSeries A Preferred StockConversionDerivative units7,127,019Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 30 · 2d laterSEC filing
DirectorSeries B Preferred StockConversionDerivative units1,333,975Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 30 · 2d laterSEC filing
DirectorSeries B-1 Preferred StockConversionDerivative units513,067Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 30 · 2d laterSEC filing
DirectorSeries C Preferred StockConversionDerivative units256,448Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 30 · 2d laterSEC filing
DirectorCommon StockConversion10,690,530Price not reportedUnavailableSep 28Filed Sep 30 · 2d laterSEC filing
DirectorCommon StockConversion2,000,962Price not reportedUnavailableSep 28Filed Sep 30 · 2d laterSEC filing
DirectorCommon StockConversion769,601Price not reportedUnavailableSep 28Filed Sep 30 · 2d laterSEC filing
DirectorCommon StockConversion564,187Price not reportedUnavailableSep 28Filed Sep 30 · 2d laterSEC filing
DirectorCommon StockPurchase300,249$17.00 / share$5.1MSep 28Filed Sep 30 · 2d laterSEC filing
DirectorCommon StockConversion7,127,019Price not reportedUnavailableSep 28Filed Sep 30 · 2d laterSEC filing
DirectorCommon StockConversion1,333,975Price not reportedUnavailableSep 28Filed Sep 30 · 2d laterSEC filing
DirectorCommon StockConversion513,067Price not reportedUnavailableSep 28Filed Sep 30 · 2d laterSEC filing
DirectorCommon StockConversion256,448Price not reportedUnavailableSep 28Filed Sep 30 · 2d laterSEC filing
DirectorCommon StockPurchase2 trades649,751avg $17.00 / share$11.05MSep 28Filed Sep 30 · 2d later
2 filings
  • 61,516 @ $17.00 · $1.05MSEC filing
  • 588,235 @ $17.00 · $10MSEC filing
DirectorSeries A Preferred StockConversionDerivative units10,690,530Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 30 · 2d laterSEC filing
DirectorSeries B Preferred StockConversionDerivative units2,000,962Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 30 · 2d laterSEC filing
DirectorSeries B-1 Preferred StockConversionDerivative units769,601Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 30 · 2d laterSEC filing
DirectorSeries C Preferred StockConversionDerivative units564,187Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 30 · 2d laterSEC filing
DirectorSeries A Preferred StockConversionDerivative units7,127,019Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 30 · 2d laterSEC filing
DirectorSeries B Preferred StockConversionDerivative units1,333,975Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 30 · 2d laterSEC filing
DirectorSeries B-1 Preferred StockConversionDerivative units513,067Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 30 · 2d laterSEC filing
DirectorSeries C Preferred StockConversionDerivative units256,448Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 30 · 2d laterSEC filing
+4DirectorCommon StockConversion10,690,530Price not reportedUnavailableSep 28Filed Sep 30 · 2d laterSEC filing
+4DirectorCommon StockConversion2,000,962Price not reportedUnavailableSep 28Filed Sep 30 · 2d laterSEC filing
+4DirectorCommon StockConversion769,601Price not reportedUnavailableSep 28Filed Sep 30 · 2d laterSEC filing
+4DirectorCommon StockConversion564,187Price not reportedUnavailableSep 28Filed Sep 30 · 2d laterSEC filing
+4DirectorCommon StockPurchase300,249$17.00 / share$5.1MSep 28Filed Sep 30 · 2d laterSEC filing
+4DirectorCommon StockConversion7,127,019Price not reportedUnavailableSep 28Filed Sep 30 · 2d laterSEC filing
+4DirectorCommon StockConversion1,333,975Price not reportedUnavailableSep 28Filed Sep 30 · 2d laterSEC filing
+4DirectorCommon StockConversion513,067Price not reportedUnavailableSep 28Filed Sep 30 · 2d laterSEC filing
+4DirectorCommon StockConversion256,448Price not reportedUnavailableSep 28Filed Sep 30 · 2d laterSEC filing
+4DirectorCommon StockPurchase2 trades649,751avg $17.00 / share$11.05MSep 28Filed Sep 30 · 2d later
2 filings
  • 61,516 @ $17.00 · $1.05MSEC filing
  • 588,235 @ $17.00 · $10MSEC filing
+4DirectorSeries A Preferred StockConversionDerivative units10,690,530Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 30 · 2d laterSEC filing
+4DirectorSeries B Preferred StockConversionDerivative units2,000,962Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 30 · 2d laterSEC filing
+4DirectorSeries B-1 Preferred StockConversionDerivative units769,601Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 30 · 2d laterSEC filing
+4DirectorSeries C Preferred StockConversionDerivative units564,187Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 30 · 2d laterSEC filing
+4DirectorSeries A Preferred StockConversionDerivative units7,127,019Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 30 · 2d laterSEC filing
+4DirectorSeries B Preferred StockConversionDerivative units1,333,975Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 30 · 2d laterSEC filing
+4DirectorSeries B-1 Preferred StockConversionDerivative units513,067Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 30 · 2d laterSEC filing
+4DirectorSeries C Preferred StockConversionDerivative units256,448Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 30 · 2d laterSEC filing
10% ownerCommon StockConversion3,334,938Price not reportedUnavailableSep 28Filed Sep 29 · 1d laterSEC filing
10% ownerCommon StockConversion1,113,666Price not reportedUnavailableSep 28Filed Sep 29 · 1d laterSEC filing
10% ownerCommon StockConversion512,897Price not reportedUnavailableSep 28Filed Sep 29 · 1d laterSEC filing
10% ownerCommon StockPurchase592,593$17.00 / share$10.07MSep 28Filed Sep 29 · 1d laterSEC filing
10% ownerCommon StockConversion1,538,691Price not reportedUnavailableSep 28Filed Sep 29 · 1d laterSEC filing
10% ownerCommon StockPurchase414,814$17.00 / share$7.05MSep 28Filed Sep 29 · 1d laterSEC filing
10% ownerCommon StockConversion1,667,468Price not reportedUnavailableSep 28Filed Sep 29 · 1d laterSEC filing
10% ownerCommon StockConversion169,001Price not reportedUnavailableSep 28Filed Sep 29 · 1d laterSEC filing
10% ownerCommon StockPurchase592,593$17.00 / share$10.07MSep 28Filed Sep 29 · 1d laterSEC filing
10% ownerSeries B Preferred StockConversionDerivative units3,907,547Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 29 · 1d laterSEC filing
10% ownerSeries B-1 Preferred StockConversionDerivative units1,304,883Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 29 · 1d laterSEC filing
10% ownerSeries C Preferred StockConversionDerivative units600,962Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 29 · 1d laterSEC filing
10% ownerSeries C Preferred StockConversionDerivative units1,802,885Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 29 · 1d laterSEC filing
10% ownerSeries B Preferred StockConversionDerivative units1,953,773Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 29 · 1d laterSEC filing
10% ownerSeries B-1 Preferred StockConversionDerivative units198,019Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 29 · 1d laterSEC filing
DirectorCommon StockConversion3,334,938Price not reportedUnavailableSep 28Filed Sep 29 · 1d laterSEC filing
DirectorCommon StockConversion1,113,666Price not reportedUnavailableSep 28Filed Sep 29 · 1d laterSEC filing
DirectorCommon StockConversion512,897Price not reportedUnavailableSep 28Filed Sep 29 · 1d laterSEC filing
DirectorCommon StockPurchase592,593$17.00 / share$10.07MSep 28Filed Sep 29 · 1d laterSEC filing
DirectorCommon StockConversion1,538,691Price not reportedUnavailableSep 28Filed Sep 29 · 1d laterSEC filing
DirectorCommon StockPurchase414,814$17.00 / share$7.05MSep 28Filed Sep 29 · 1d laterSEC filing
DirectorCommon StockConversion1,667,468Price not reportedUnavailableSep 28Filed Sep 29 · 1d laterSEC filing
DirectorCommon StockConversion169,001Price not reportedUnavailableSep 28Filed Sep 29 · 1d laterSEC filing
DirectorCommon StockPurchase592,593$17.00 / share$10.07MSep 28Filed Sep 29 · 1d laterSEC filing
DirectorSeries B Preferred StockConversionDerivative units3,907,547Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 29 · 1d laterSEC filing
DirectorSeries B-1 Preferred StockConversionDerivative units1,304,883Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 29 · 1d laterSEC filing
DirectorSeries C Preferred StockConversionDerivative units600,962Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 29 · 1d laterSEC filing
DirectorSeries C Preferred StockConversionDerivative units1,802,885Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 29 · 1d laterSEC filing
DirectorSeries B Preferred StockConversionDerivative units1,953,773Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 29 · 1d laterSEC filing
DirectorSeries B-1 Preferred StockConversionDerivative units198,019Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 29 · 1d laterSEC filing
+210% ownerCommon StockConversion8,908,775Price not reportedUnavailableSep 28Filed Sep 29 · 1d laterSEC filing
+210% ownerCommon StockConversion1,667,469Price not reportedUnavailableSep 28Filed Sep 29 · 1d laterSEC filing
+210% ownerCommon StockConversion513,067Price not reportedUnavailableSep 28Filed Sep 29 · 1d laterSEC filing
+210% ownerCommon StockConversion153,868Price not reportedUnavailableSep 28Filed Sep 29 · 1d laterSEC filing
+210% ownerCommon StockConversion307,738Price not reportedUnavailableSep 28Filed Sep 29 · 1d laterSEC filing
+210% ownerCommon StockConversion307,738Price not reportedUnavailableSep 28Filed Sep 29 · 1d laterSEC filing
+210% ownerSeries A Preferred StockConversionDerivative units10,438,412Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 29 · 1d laterSEC filing
+210% ownerSeries B Preferred StockConversionDerivative units1,953,774Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 29 · 1d laterSEC filing
+210% ownerSeries B-1 Preferred StockConversionDerivative units601,161Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 29 · 1d laterSEC filing
+210% ownerSeries C Preferred StockConversionDerivative units180,288Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 29 · 1d laterSEC filing
+210% ownerSeries C Preferred StockConversionDerivative units360,577Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 29 · 1d laterSEC filing
+210% ownerSeries C Preferred StockConversionDerivative units360,577Exercise / conversion price not reportedNot a separate purchaseSep 28Filed Sep 29 · 1d laterSEC filing
Chief Technology OfficerEmployee Stock Option (right to buy)Grant or awardDerivative units512,076Award · no purchase priceNon-cash awardSep 24Filed Sep 28 · 4d laterSEC filing
Chief Scientific OfficerEmployee Stock Option (right to buy)Grant or awardDerivative units170,692Award · no purchase priceNon-cash awardSep 24Filed Sep 28 · 4d laterSEC filing
CFO and CBOEmployee Stock Option (right to buy)Grant or awardDerivative units170,692Award · no purchase priceNon-cash awardSep 24Filed Sep 28 · 4d laterSEC filing
President and CEOEmployee Stock Option (right to buy)Grant or awardDerivative units1,024,152Award · no purchase priceNon-cash awardSep 24Filed Sep 28 · 4d laterSEC filing
Chief People OfficerEmployee Stock Option (right to buy)Grant or awardDerivative units85,346Award · no purchase priceNon-cash awardSep 24Filed Sep 28 · 4d laterSEC filing

Congress transactions 0

All Congress filings
No disclosed congressional trades for ADRX in the imported filings.

This reflects the filings imported so far, not a complete trading history.

Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

Qualifying common-equity purchase value

$87,745,772 of common-equity purchase value after transaction-age decay across 180 days.

+25 pts

Distinct buying groups

5 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.

+20 pts

Insider buying cluster

5 buying groups inside 30 transaction-date days, public by the snapshot cutoff.

+15 pts

Material reported holdings increase

At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.

+10 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0001802369
Latest public acceptance
Sep 30, 2026, 09:29 PM UTC
Score calculated
Oct 8, 2026, 12:11 AM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.